Current Edition


Real-world evidence shows clinically meaningful weight loss in people receiving Saxenda®

People treated with Saxenda® (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in a real-world clinical setting, in …

Continue Reading →

Shield Therapeutics 2017 Loss Widens On Clinical Trials, Higher Costs

Shield Therapeutics PLC on Wednesday reported significantly widened loss for 2017, as it progresses on Feraccru product study and commercialisation. The specialty pharmaceutical firm reported …

Continue Reading →